Alzamend Neuro, Inc(ALZN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALZN Alzamend Neuro, Inc

休市中 07-24 16:00:00 EDT

1.33

+0.07

+5.56%

盘后1.35

+0.02+1.50%

19:34 EDT

最高1.37	最低1.23	成交量4.94万
今开1.26	昨收1.26	日振幅11.11%
总市值637.27万	流通市值635.70万	总股本479.15万
成交额6.46万	换手率1.03%	流通股本477.97万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALZN","market":"US","secType":"STK","nameCN":"Alzamend Neuro, Inc","latestPrice":1.33,"timestamp":1784923200000,"preClose":1.26,"halted":0,"volume":49444,"hourTrading":{"tag":"盘后","latestPrice":1.35,"preClose":1.33,"latestTime":"19:34 EDT","volume":550,"amount":739.0598,"timestamp":1784936048994,"change":0.02,"changeRate":0.015038,"amplitude":0.015038},"delay":0,"changeRate":0.0555555555555556,"floatShares":4779700,"shares":4791500,"eps":-2.99368,"marketStatus":"休市中","change":0.07,"latestTime":"07-24 16:00:00 EDT","open":1.26,"high":1.37,"low":1.23,"amount":64568.573491999996,"amplitude":0.111111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.99368,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"listingDate":1623729600000,"exchange":"NASDAQ","adjPreClose":1.26,"preHourTrading":{"tag":"盘前","latestPrice":1.28,"preClose":1.26,"latestTime":"07:00 EDT","volume":33,"amount":42.24,"timestamp":1784890812989,"change":0.02,"changeRate":0.015873,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.35,"preClose":1.33,"latestTime":"19:34 EDT","volume":550,"amount":739.0598,"timestamp":1784936048994,"change":0.02,"changeRate":0.015038,"amplitude":0.015038},"volumeRatio":0.9572375548137347,"impliedVol":1.3738,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ALZN","defaultTab":"news","newsList":[{"id":"1152892938","title":"Alzamend Neuro公布AL001“脑内锂”研究II期临床试验积极药效学数据，试验于麻省总医院进行","url":"https://stock-news.laohu8.com/highlight/detail?id=1152892938","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152892938?lang=zh_cn&edition=full","pubTime":"2026-04-07 20:02","pubTimestamp":1775563336,"startTime":"0","endTime":"0","summary":"Alzamend Neuro公司宣布，其候选药物AL001（即“脑内锂”研究）在位于马萨诸塞州总医院进行的II期临床试验中，获得了令人鼓舞的药效学数据。这些积极结果标志着公司在开发新型锂疗法用于治疗神经精神疾病方面取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALZN","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109281931","title":"Alzamend Neuro公司针对重度抑郁症、创伤后应激障碍及阿尔茨海默病的额外II期研究预计将于2026年下半年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1109281931","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109281931?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:02","pubTimestamp":1774526544,"startTime":"0","endTime":"0","summary":"Alzamend Neuro公司宣布，其针对重度抑郁症、创伤后应激障碍以及阿尔茨海默病的额外II期临床研究，预计将在2026年下半年度正式启动。这一进展标志着公司在神经疾病治疗领域的研发管线取得了重要推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170545644","title":"Alzamend Neuro公司AL001实现总锂血液暴露量达101%，峰值水平较标准碳酸锂高出97%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170545644","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170545644?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:02","pubTimestamp":1774526535,"startTime":"0","endTime":"0","summary":"Alzamend Neuro公司宣布，其研发的AL001在关键指标上表现出显著优势。与标准碳酸锂制剂相比，AL001实现了总锂血液暴露量达到101%的优异结果。同时，其血液中的峰值锂水平也比标准碳酸锂高出97%。\n这一数据突显了AL001在药物递送效率和生物利用度方面的潜在突破，为阿尔茨海默病及相关神经系统疾病的治疗带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131383143","title":"Alzamend Neuro公布AL001“锂入脑”研究II期临床试验积极顶线数据；AL001实现生物等效性并在所有测量脑区展现卓越脑部递送能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1131383143","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131383143?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:02","pubTimestamp":1774526534,"startTime":"0","endTime":"0","summary":"Alzamend Neuro公司宣布，其针对AL001（即“锂入脑”研究）的II期临床试验获得了积极的顶线结果。数据显示，AL001不仅达到了生物等效性的标准，更在所有受测脑区均表现出卓越的脑部递送效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALZN","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518784337","title":"Alzamend Neuro(ALZN.US)：2025年Q3财报实现营收0美元，前值为0美元；每股收益为-0.19美元，前值为-3.77美元，预期值为-0.77美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518784337","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518784337?lang=zh_cn&edition=full","pubTime":"2025-03-11 06:02","pubTimestamp":1741644161,"startTime":"0","endTime":"0","summary":"Alzamend Neuro(ALZN.US)：2025年Q3财报实现营收0美元，前值为0美元；每股收益为-0.19美元，前值为-3.77美元，预期值为-0.77美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11060248643293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ALZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518279743","title":"Alzamend Neuro, Inc.盘中异动 快速跳水7.88%报0.700美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518279743?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:46","pubTimestamp":1741617993,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时46分，Alzamend Neuro, Inc.股票出现波动，股价快速跳水7.88%。截至发稿，该股报0.700美元/股，成交量1.9976万股，换手率0.30%，振幅5.20%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3490.73%、769.25%、669.92%，振幅较大的相关个股有Scisparc Ltd.、Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为45.34%、41.36%、40.33%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310224633a26a4194&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310224633a26a4194&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ALZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517943171","title":"Alzamend Neuro, Inc.盘中异动 下午盘股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517943171?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:12","pubTimestamp":1741288372,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时12分，Alzamend Neuro, Inc.股票出现异动，股价急速下跌5.45%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，Plus Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为4980.36%、3825.28%、256.76%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为125.28%、122.63%、71.44%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307031253a262d2af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307031253a262d2af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ALZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516428608","title":"Alzamend Neuro, Inc.盘中异动 快速跳水5.82%报0.712美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516428608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516428608?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:05","pubTimestamp":1741100734,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时05分，Alzamend Neuro, Inc.股票出现波动，股价急速下挫5.82%。截至发稿，该股报0.712美元/股，成交量3.9314万股，换手率0.72%，振幅1.91%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304230534abe7fa1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304230534abe7fa1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ALZN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516650799","title":"Alzamend Neuro, Inc.盘中异动 大幅下挫6.10%报0.770美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516650799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516650799?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:03","pubTimestamp":1741032205,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时03分，Alzamend Neuro, Inc.股票出现波动，股价急速下挫6.10%。截至发稿，该股报0.770美元/股，成交量13.7119万股，换手率2.52%，振幅6.70%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4576.51%、211.83%、182.42%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040325a25d9bee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040325a25d9bee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALZN","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516837308","title":"Alzamend Neuro, Inc.盘中异动 下午盘股价大跌5.67%报0.790美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516837308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516837308?lang=zh_cn&edition=full","pubTime":"2025-03-01 02:34","pubTimestamp":1740767651,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日02时34分，Alzamend Neuro, Inc.股票出现波动，股价大幅下跌5.67%。截至发稿，该股报0.790美元/股，成交量5.3085万股，换手率0.98%，振幅7.18%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010234119896b00d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010234119896b00d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALZN","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514885124","title":"Alzamend Neuro, Inc.盘中异动 早盘股价大涨5.34%报0.898美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514885124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514885124?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:08","pubTimestamp":1740582525,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时08分，Alzamend Neuro, Inc.股票出现异动，股价急速上涨5.34%。截至发稿，该股报0.898美元/股，成交量2.2585万股，换手率0.42%，振幅3.69%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为4752.72%、171.26%、152.41%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Organovo Holdings, Inc.，振幅分别为161.02%、39.47%、33.94%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230846963156db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230846963156db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALZN","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513783977","title":"Alzamend Neuro, Inc.股价重挫14.18% 市值跌14.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513783977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513783977?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:08","pubTimestamp":1740409710,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时08分，Alzamend Neuro, Inc.股票出现异动，股价急速下挫14.18%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为166.79%、73.17%、26.05%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230830a2521dca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230830a2521dca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ALZN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513529116","title":"Alzamend Neuro, Inc.盘中异动 早盘快速下跌5.39%报0.965美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513529116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513529116?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:36","pubTimestamp":1740148575,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时36分，Alzamend Neuro, Inc.股票出现异动，股价大幅跳水5.39%。截至发稿，该股报0.965美元/股，成交量6.4372万股，换手率1.18%，振幅2.94%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223616a24eb19f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223616a24eb19f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALZN","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512527485","title":"Alzamend Neuro, Inc.盘中异动 股价大涨6.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512527485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512527485?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:30","pubTimestamp":1739975424,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时30分，Alzamend Neuro, Inc.股票出现波动，股价大幅上涨6.48%。截至发稿，该股报1.15美元/股，成交量1088.26万股，换手率200.31%，振幅0.00%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为201.39%、198.27%、65.18%，振幅较大的相关个股有Azitra Inc、Actinium Pharmaceuticals, Inc. 、Aim Immunotech Inc.，振幅分别为11.29%、3.56%、3.36%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223024988b30f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223024988b30f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALZN","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509266997","title":"Alzamend Neuro, Inc.盘中异动 临近午盘股价大跌5.04%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509266997","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509266997?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:31","pubTimestamp":1738945893,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时31分，Alzamend Neuro, Inc.股票出现异动，股价急速下跌5.04%。截至发稿，该股报1.13美元/股，成交量1.4029万股，换手率0.26%，振幅4.20%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208003133987dc356&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208003133987dc356&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ALZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501771974","title":"Alzamend Neuro, Inc.盘中异动 早盘大幅下跌5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501771974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501771974?lang=zh_cn&edition=full","pubTime":"2025-01-08 23:43","pubTimestamp":1736351030,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日23时43分，Alzamend Neuro, Inc.股票出现异动，股价急速下跌5.65%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为3034.24%、574.03%、550.79%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为192.73%、139.44%、87.82%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010823435095fd0cdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010823435095fd0cdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALZN","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501786489","title":"Alzamend Neuro, Inc.盘中异动 早盘大幅跳水7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501786489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501786489?lang=zh_cn&edition=full","pubTime":"2025-01-07 23:44","pubTimestamp":1736264671,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日23时44分，Alzamend Neuro, Inc.股票出现异动，股价急速下跌7.09%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Hoth Therapeutics, Inc.、Alpha Tau Medical Ltd C/Wts 、Cero Therapeutics Holdings, Inc.涨幅较大，Hoth Therapeutics, Inc.、Immuneering Corporation、Scisparc Ltd.较为活跃，换手率分别为3412.42%、217.64%、130.36%，振幅较大的相关个股有Hoth Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alpha Tau Medical Ltd C/Wts ，振幅分别为272.08%、86.33%、61.67%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010723443195fbab93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010723443195fbab93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ALZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500320140","title":"Alzamend Neuro, Inc.盘中异动 下午盘股价大涨6.67%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500320140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500320140?lang=zh_cn&edition=full","pubTime":"2025-01-04 02:36","pubTimestamp":1735929412,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日02时36分，Alzamend Neuro, Inc.股票出现异动，股价快速拉升6.67%。截至发稿，该股报1.28美元/股，成交量6.4519万股，换手率1.19%，振幅5.00%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104023652a21499ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104023652a21499ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALZN","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500974510","title":"Alzamend Neuro, Inc.盘中异动 快速拉升5.07%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500974510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500974510?lang=zh_cn&edition=full","pubTime":"2025-01-03 01:02","pubTimestamp":1735837346,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日01时02分，Alzamend Neuro, Inc.股票出现波动，股价急速上涨5.07%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，Revelation Biosciences Inc C/Wts 10/01/2027 、Celularity Inc C/Wts 16/07/2026 、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Revelation Biosciences, Inc.、Mustang Bio, Inc.、知临集团较为活跃，换手率分别为1191.98%、279.26%、203.43%，振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Mustang Bio, Inc.、Revelation Biosciences, Inc.，振幅分别为170.00%、146.61%、136.01%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010301022695f6b731&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010301022695f6b731&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALZN","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500647745","title":"Alzamend Neuro, Inc.盘中异动 急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500647745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500647745?lang=zh_cn&edition=full","pubTime":"2025-01-01 04:34","pubTimestamp":1735677291,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日04时34分，Alzamend Neuro, Inc.股票出现波动，股价大幅下跌5.00%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Onconetix, Inc.、知临集团、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为3120.71%、2014.30%、359.30%，振幅较大的相关个股有知临集团、Onconetix, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为309.22%、265.45%、248.39%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101043451a210ce19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101043451a210ce19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ALZN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alzamend.com","stockEarnings":[{"period":"1week","weight":0.0992},{"period":"1month","weight":-0.0292},{"period":"3month","weight":0.1982},{"period":"6month","weight":-0.3955},{"period":"1year","weight":-0.5552},{"period":"ytd","weight":-0.2692}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alzamend Neuro, Inc.于2016年2月26日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于开发治疗阿尔茨海默病、躁郁症、重度抑郁症和创伤后应激障碍的新产品。该公司推出了两款候选产品，目标不仅是为阿尔茨海默症带来治疗，还包括双相情感障碍、重度抑郁症和创伤后应激障碍。该公司开发了一种通过免疫疗法对抗阿尔茨海默氏症的新方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.021244},{"month":2,"riseRate":0.2,"avgChangeRate":-0.139445},{"month":3,"riseRate":0.6,"avgChangeRate":-0.078127},{"month":4,"riseRate":0.4,"avgChangeRate":-0.080103},{"month":5,"riseRate":0.4,"avgChangeRate":-0.046325},{"month":6,"riseRate":0.2,"avgChangeRate":-0.188587},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.131699},{"month":8,"riseRate":0.4,"avgChangeRate":-0.193815},{"month":9,"riseRate":0.4,"avgChangeRate":-0.01602},{"month":10,"riseRate":0.2,"avgChangeRate":-0.167499},{"month":11,"riseRate":0,"avgChangeRate":-0.126469},{"month":12,"riseRate":0,"avgChangeRate":-0.232408}],"exchange":"NASDAQ","name":"Alzamend Neuro, Inc","nameEN":"Alzamend Neuro, Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alzamend Neuro, Inc(ALZN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Alzamend Neuro, Inc(ALZN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Alzamend Neuro, Inc,ALZN,Alzamend Neuro, Inc股票,Alzamend Neuro, Inc股票老虎,Alzamend Neuro, Inc股票老虎国际,Alzamend Neuro, Inc行情,Alzamend Neuro, Inc股票行情,Alzamend Neuro, Inc股价,Alzamend Neuro, Inc股市,Alzamend Neuro, Inc股票价格,Alzamend Neuro, Inc股票交易,Alzamend Neuro, Inc股票购买,Alzamend Neuro, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alzamend Neuro, Inc(ALZN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Alzamend Neuro, Inc(ALZN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}